🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

globenewswire.com/news-release/2…

We’re happy to share that BioAge’s BGE-102—a potent, brain-penetrant, once-daily oral NLRP3 inhibitor—has completed IND-enabling studies and is advancing toward the clinic, with Phase 1 single-ascending-dose (SAD) data expected by year-end. Read the release:

Today, our CEO Kristen Fortney is speaking at the 2025 Paul F. Glenn/AFAR Conference on the Biology of Aging, an annual meeting that brings together leading researchers advancing our understanding of aging biology and its therapeutic applications. Her talk, "From Human Data to

What if the secret to treating metabolic diseases lies in understanding why some people age more successfully than others? Our CEO Kristen Fortney recently explored this question on RBC Capital Markets' "Pathfinders in Biopharma" podcast, diving deep into how BioAge is translating

We’re pleased to announce that BioAge is expanding our preclinical APJ agonist pipeline with highly potent oral small-molecule and injectable candidates designed to address key unmet needs in obesity treatment. APJ agonists are designed to mimic the effects of apelin, an

The @bioagepodcast features the people & companies advancing the science of human longevity and discovering drugs to extend healthspan. Our newest episode just dropped!

"Of all the things we know about, the one that rises to the very top is exercise. In fact, it's the only intervention in people that has shown any effect on slowing the body-wide aging clock," says cardiologist and author Eric Topol in the Washington Post. This is exactly why

BioAge is excited to kick off a new initiative with Norway’s HUNT Biobank - one of Europe's most comprehensive population health studies - to map how molecular changes across decades shape healthy aging. globenewswire.com/news-release/2… Through our collaboration with Norwegian

The tremendous success of GLP-1/GIP receptor agonists is rewriting the playbook for metabolic diseases. At #BIO2025, BioAge CEO Kristen Fortney will participate in an expert panel to discuss how the rapidly evolving therapeutic landscape has opened the door for next-generation

"It's like building a roadmap of human aging biology that can show us exactly where and when to intervene." — BioAge COO & co-founder Eric Morgen on the power of large-scale profiling of longitudinal aging data to yield new therapeutic targets. BioAge recently announced an

Highlights from the fascinating panel discussion "Weight Loss for Longevity? How Metabolic Drugs are Disrupting Chronic Disease and Improving Healthspan" at #BIO2025 yesterday... "Not even a decade ago, people thought, 'Obesity will never be a huge indication - no one's going to

The future of drug discovery is rooted in human biology—starting with preclinical human models that boost translational success. At #BIO2025, BioAge CEO Kristen Fortney joined the panel “Replacing Guesswork with Data: How Preclinical Human Models Are Driving More Predictive Drug

Proud to share that BioAge presented some of our compelling new preclinical data on APJ agonism at the American Diabetes Association's 85th Scientific Sessions this week. BioAge is advancing next-generation APJ agonists to translate this promising biology into new therapies for obesity and its

At Discovery & Development Europe 2025 in Basel this week, our VP-Data Science Naisha Shah, PhD, showcased how human aging data can transform drug target discovery. In her talk "Targeting aging biology: exercise induced pathways for the treatment of neurodegenerative disease,"

Excited to share our new preprint on our research providing detailed structural insights into BioAge’s novel class of brain-penetrant NLRP3 inhibitors, targeting a core driver of metabolic aging. In this study, we identified a new binding pocket on NLRP3 and demonstrated how it

The @bioagepodcast features the people & companies advancing the science of human longevity and discovering drugs to extend healthspan. Our newest episode just dropped!

globenewswire.com/news-release/2…